NUTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Nutex Health Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Core Viewpoint - A class action lawsuit has been filed against Nutex Health Inc. and certain officers for alleged violations of federal securities laws during the class period from August 8, 2024, to August 14, 2025 [1][2]. Summary by Sections Class Definition - The lawsuit aims to recover damages for all individuals and entities that purchased or acquired Nutex securities within the specified class period [2]. Case Details - The Complaint alleges that Defendants made materially false and misleading statements, including: - HaloMD was involved in a scheme to defraud insurance companies, generating unsustainable revenues for Nutex [3]. - Nutex overstated its remediation of internal control weaknesses and misclassified stock-based compensation obligations [3]. - The Company faced increased risks of failing to file timely financial reports with the SEC, leading to an overstatement of its business and financial prospects [3]. Next Steps - Interested parties can review the Complaint and have until October 21, 2025, to request appointment as lead plaintiff [4]. Legal Representation - The law firm operates on a contingency fee basis, meaning they will only collect fees if successful in recovering funds for investors [5]. Firm Background - Bronstein, Gewirtz & Grossman, LLC is recognized for representing investors in securities fraud class actions and has recovered hundreds of millions for clients [6].